Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial ribosomal protein S10 pseudogene 2 (MRPS10P2) is a nongenic, non-coding pseudogene related to the mitochondrial ribosomal protein S10 gene. As a pseudogene, MRPS10P2 does not encode a functional protein and has no direct role as a receptor, enzyme, transporter, or other classical therapeutic target[1][5][6]. Pseudogenes arise by duplication or retrotransposition and typically accumulate disabling mutations that prevent protein expression. Although pseudogenes can sometimes be involved in gene regulation (for example, acting as decoys for regulatory RNAs or producing non-coding RNAs with regulatory functions), there is no evidence that MRPS10P2 has any such impact or relevance as a therapeutic target. The aliases provided (MRPS10P2, MRPS10P3, MRPS10P4) refer to similar or related pseudogenes within the mitochondrial ribosomal protein S10 pseudogene family[1]. MRPS10P2 is *not a molecular target* in the drug discovery or therapeutic sense. There is apparent confusion in the aliases: MRPS10P3 and MRPS10P4 are likely other, distinct pseudogenes, but may have been conflated as aliases due to gene family naming conventions[1]. There are *no known drugs, disease roles, or biomarkers* associated with MRPS10P2, nor is it implicated in any protein-mediated function, safety concern, or therapeutic challenge. Overall, **MRPS10P2 is a pseudogene, not a functional gene or receptor, and thus not a therapeutic target**[1][6]. If a functional or druggable mitochondrial ribosomal protein S10 is desired, the correct target would be *mitochondrial ribosomal protein S10* (MRPS10), not its pseudogenes[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial ribosomal protein S10 pseudogene 2 (MRPS10P2).